サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1683387

肺ステントの世界市場：2025年～2033年

Global Lung Stents Market - 2025-2033

出版日
ページ情報
英文 159 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
肺ステントの世界市場：2025年～2033年
出版日: 2025年03月20日
発行: DataM Intelligence
ページ情報: 英文 159 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の肺ステンの市場規模は、2024年に1億7,557万米ドルに達し、2033年には5億7,998万米ドルに達すると予測され、予測期間の2025年～2033年のCAGRは12.6%になる見込みです。

肺ステントは、肺がん、気管気管支狭窄、COPDなどの疾患により気道が閉塞したり狭くなったりした患者の気道開存性を維持するために使用される医療機器です。管状のインプラントは気道の虚脱を防ぎ、正常な呼吸を促します。金属製、シリコン製、またはハイブリッド製で、柔軟性、耐久性、抜去の容易さを備えています。気管支鏡による低侵襲手術で一般的に使用され、呼吸器合併症の緩和や肺機能の改善をもたらします。

世界の肺ステント市場は、肺がん、COPD、気管気管支狭窄などの呼吸器疾患の増加により成長しています。これらの疾患は気道閉塞や呼吸困難を引き起こすため、ステントは気道の開存性を維持し、呼吸機能を改善するために極めて重要です。高齢化、環境汚染物質、喫煙率の高さが、世界の呼吸器疾患の急増に寄与しています。ステント留置のような低侵襲治療への需要が市場拡大を後押ししています。薬剤溶出性ステントや生分解性ステントなどのステント材料の進歩により、治療成績はさらに向上します。

例えば、2020年のCOPD有病率は世界全体で10.6%であり、4億8,000万人の患者が発生しています。2050年には1億1,200万人増の5億9,200万人になり、2020年から2050年にかけて23.3％増加すると予測されています。この増加は主に女性や低・中所得国（LMIC）でのCOPD負担の増加によるものです。したがって、呼吸器疾患の増加は、肺ステント需要の必要性を高め、予測期間中の市場全体の成長を後押しします。

肺ステントは、その利点にもかかわらず、ステントの移動、肉芽組織の形成、感染症などのリスクを伴い、その普及を妨げる可能性があります。ステントの長期留置は気道刺激、閉塞、細菌感染を引き起こす可能性があり、追加の医療介入が必要となります。ステントの除去や交換の処置が複雑であることも、ヘルスケア専門家の課題に拍車をかけています。

当レポートでは、世界の肺ステント市場について調査し、市場の概要とともに、製品タイプ別、材料別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場のイントロダクションと範囲

第2章 エグゼクティブの洞察と重要なポイント

第3章 市場力学

  • 影響要因
    • 促進要因
    • 抑制要因
    • 機会
    • 影響分析

第4章 戦略的洞察と業界の展望

  • 市場のリーダーと先駆者
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格動向
  • キーオピニオンリーダー

第5章 製品タイプ別

  • 気管ステント
  • 気管支ステント
  • その他

第6章 材料別

  • 金属ステント
  • シリコンステント
  • ハイブリッドステント

第7章 エンドユーザー別

  • 病院
  • 外来手術センター
  • 専門クリニック
  • その他

第8章 地域市場分析と成長機会

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他
  • ラテンアメリカ
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他
  • 中東・アフリカ

第9章 競合情勢と市場ポジショニング

第10章 企業プロファイル

  • Boston Scientific Corporation
  • Cook Medical
  • ELLA-CS, sro
  • Merit Medical Systems, Inc.
  • Novatech SA
  • Micro-Tech（Nanjing）Co., Ltd.
  • S&G Biotech Inc.
  • Medorah Meditek Pvt. Ltd
  • Mitrai Industries
  • E. Benson Hood Laboratories, Inc

第11章 仮定と調査手法

第12章 付録

目次
Product Code: PH9326

The global lung stents market reached US$ 175.57 million in 2024 and is expected to reach US$ 579.98 million by 2033, growing at a CAGR of 12.6% during the forecast period 2025-2033.

Lung stents are medical devices used to maintain airway patency in patients with obstructed or narrowed airways due to conditions like lung cancer, tracheobronchial stenosis, or COPD. These tubular-shaped implants prevent airway collapse and facilitate normal breathing. Made from metal, silicone, or hybrid combinations, they offer flexibility, durability, and ease of removal. They are commonly used in minimally invasive procedures via bronchoscopy, providing relief for respiratory complications and improving lung function.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Respiratory Diseases

The global lung stents market is growing due to the rise in respiratory diseases like lung cancer, COPD and tracheobronchial stenosis. These conditions cause airway obstruction and breathing difficulties, making stents crucial for maintaining airway patency and improving respiratory function. The aging population, environmental pollutants, and high smoking rates contribute to the surge in respiratory cases worldwide. The demand for minimally invasive treatments like stent placements is boosting market expansion. Advancements in stent Material, including drug-eluting and biodegradable stents, further enhance treatment outcomes.

For instance, in 2020, COPD prevalence was 10.6% globally, resulting in 480 million cases. By 2050, it is projected to increase by 112 million to 592 million, a 23.3% increase from 2020 to 2050. This rise is primarily due to the rising COPD burden among females and in low- and middle-income countries (LMICs). Hence, the rise in the respiratory diseases indeed the need for lung stents demand are raised which helps the overall market to grow during the forecast period.

Complications and Risk of Stent-Related Infections

Lung stents, despite their benefits, carry risks like stent migration, granulation tissue formation and infections, which can hinder their widespread use. Prolonged stent placement can cause airway irritation, obstruction, or bacterial infections, necessitating additional medical intervention. The complexity of stent removal and replacement procedures adds to healthcare professionals' challenges.

Segment Analysis

The global lung stents market is segmented based on product type, material, end-user and region.

Product Type:

The tracheal stents from product type segment is expected to dominate the lung stents market

The tracheal stents holds is a significant position in the global lung stents market, providing life-saving solutions for patients with tracheal obstructions. These stents maintain airway patency, improving patient quality of life. Demand for tracheal stents is growing due to respiratory diseases and minimally invasive procedures. Innovations in stent materials, such as self-expanding metal and bioresorbable stents, have enhanced their effectiveness. Focusing on patient-specific customization and improved biocompatibility, tracheal stents drive market growth in emergency and long-term respiratory care.

For instance, in March 2022, Micro-Tech Endoscopy has introduced the first self-expanding tracheobronchial nitinol y-stent, the Y-Shaped Tracheal Stent System, designed for flexible and compliant treatment of malignant neoplasms at the tracheobronchial carina. Hence, the above solution helps for complex tracheobronchial obstructions, improving patient outcomes and procedural flexibility. This product also drives market growth by increasing the adoption of self-expanding nitinol stents in airway management.

Geographical Analysis

North America is expected to hold a significant position in the lung stents market with the highest market share

North America dominates the global lung stents market due to high prevalence of respiratory diseases like COPD and lung cancer, advanced healthcare infrastructure, increased healthcare spending, and widespread adoption of minimally invasive procedures. Strong research and development initiatives, favorable reimbursement policies, and the presence of leading medical device companies support market expansion. Government funding for respiratory disease management and technological advancements in stent designs further enhance treatment outcomes, making North America a dominant player in this sector.

Additionally, rise in number of product launches, approvals also drive this region to dominate during the forecast period. For instance, in October 2024, The FDA has approved a new stent designed to open airways in patients with growing cancers. The minimally invasive AMStent system, developed by Peytant Solutions, uses a metal frame encased in human amnion, a pliable membrane that forms the amniotic sac. Amnion has been used in various medical specialties for years, including treating chronic wounds, burns, and skin ulcers.

Competitive Landscape

The major global players in the lung stents market include Boston Scientific Corporation, Cook Medical, ELLA-CS, s.r.o, Merit Medical Systems, Inc., Novatech SA, Micro-Tech (Nanjing) Co., Ltd., S&G Biotech Inc., Medorah Meditek Pvt. Ltd, Mitrai Industries and E. Benson Hood Laboratories, Inc among others.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global lung stents market report delivers a detailed analysis with 70 key tables, more than 65 visually impactful figures and 159 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Material & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Material
  • 2.5. Snippet by End-User
  • 2.6. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Respiratory Diseases
      • 3.1.1.2. Technological Advancements in Stents Designs
    • 3.1.2. Restraints
      • 3.1.2.1. Complications and Risk of Stent-Related Infections
      • 3.1.2.2. Alternative Treatment Options Available
    • 3.1.3. Opportunity
      • 3.1.3.1. Expansion in Emerging Markets
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established Leaders with Largest Selling Brand
    • 4.1.3. Market Leaders with Established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Tracheal Stents*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Bronchial Stents
  • 5.4. Others

6. By Material

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 6.1.2. Market Attractiveness Index, By Material
  • 6.2. Metal Stents*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Silicone Stents
  • 6.4. Hybrid Stents

7. By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.1.2. Market Attractiveness Index, By End-User
  • 7.2. Hospitals*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Ambulatory Surgical Centers
  • 7.4. Specialty Clinics
  • 7.5. Others

8. Regional Market Analysis and Growth Opportunities

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.6.1. U.S.
      • 8.2.6.2. Canada
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.6.1. Germany
      • 8.3.6.2. U.K.
      • 8.3.6.3. France
      • 8.3.6.4. Spain
      • 8.3.6.5. Italy
      • 8.3.6.6. Rest of Europe
  • 8.4. Latin America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.6.1. Mexico
      • 8.4.6.2. Brazil
      • 8.4.6.3. Argentina
      • 8.4.6.4. Rest of Latin America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.6.1. China
      • 8.5.6.2. India
      • 8.5.6.3. Japan
      • 8.5.6.4. South Korea
      • 8.5.6.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape and Market Positioning

  • 9.1. Competitive Overview and Key Market Players
  • 9.2. Market Share Analysis and Positioning Matrix
  • 9.3. Strategic Partnerships, Mergers & Acquisitions
  • 9.4. Key Developments in Product Portfolios and Innovations
  • 9.5. Company Benchmarking

10. Company Profiles

  • 10.1. Boston Scientific Corporation*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio
      • 10.1.2.1. Product Description
      • 10.1.2.2. Product Key Performance Indicators (KPIs)
      • 10.1.2.3. Historic and Forecasted Product Sales
      • 10.1.2.4. Product Sales Volume
    • 10.1.3. Financial Overview
      • 10.1.3.1. Company Revenue's
      • 10.1.3.2. Geographical Revenue Shares
      • 10.1.3.3. Revenue Forecasts
    • 10.1.4. Key Developments
      • 10.1.4.1. Mergers & Acquisitions
      • 10.1.4.2. Key Product Development Activities
      • 10.1.4.3. Regulatory Approvals, etc.
    • 10.1.5. SWOT Analysis
  • 10.2. Cook Medical
  • 10.3. ELLA-CS, s.r.o.
  • 10.4. Merit Medical Systems, Inc.
  • 10.5. Novatech SA
  • 10.6. Micro-Tech (Nanjing) Co., Ltd.
  • 10.7. S&G Biotech Inc.
  • 10.8. Medorah Meditek Pvt. Ltd
  • 10.9. Mitrai Industries
  • 10.10. E. Benson Hood Laboratories, Inc

LIST NOT EXHAUSTIVE

11. Assumption and Research Methodology

  • 11.1. Data Collection Methods
  • 11.2. Data Triangulation
  • 11.3. Forecasting Techniques
  • 11.4. Data Verification and Validation

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us